Detection Rates of Hepatitis B Surface and Core-related Antigens Using Novel Highly Sensitive Assays in Chronic Hepatitis B Patients With Hepatitis B Surface Antigen Seroclearance
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Okumura T, Umemura T J Gastroenterol. 2024; 60(1):129-130.
PMID: 39611969 DOI: 10.1007/s00535-024-02187-8.
References
1.
Yim H, Lok A
. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006; 43(2 Suppl 1):S173-81.
DOI: 10.1002/hep.20956.
View
2.
Hosaka T, Suzuki F, Kobayashi M, Fujiyama S, Kawamura Y, Sezaki H
. Ultrasensitive Assay for Hepatitis B Core-Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir. Hepatol Commun. 2021; 6(1):36-49.
PMC: 8710789.
DOI: 10.1002/hep4.1819.
View
3.
Inoue T, Kusumoto S, Iio E, Ogawa S, Suzuki T, Yagi S
. Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation. J Hepatol. 2021; 75(2):302-310.
DOI: 10.1016/j.jhep.2021.02.017.
View
4.
Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T
. Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody. J Gastroenterol. 2016; 52(3):376-384.
DOI: 10.1007/s00535-016-1244-7.
View
5.
Hsu Y, Huang D, Nguyen M
. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023; 20(8):524-537.
DOI: 10.1038/s41575-023-00760-9.
View